Comparable antibacterial effects and action mechanisms of ethyl cyanoacrylate nanoparticles on Bacillus subtilis and Escherichia coli evaluated by transcriptome and morphological changes
We previously demonstrated that ethyl cyanoacrylate nanoparticles (ECA-NPs) inhibit the growth specific rate of B. subtilis and E. coli under culture conditions, indicating their antibacterial effect. Exposure to ECA-NPs increased levels of reactive oxygen species (ROS), which induced oxidative stre...
Gespeichert in:
Veröffentlicht in: | Environmental science. Nano 2023-07, Vol.10 (7), p.1932-1941 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We previously demonstrated that ethyl cyanoacrylate nanoparticles (ECA-NPs) inhibit the growth specific rate of
B. subtilis
and
E. coli
under culture conditions, indicating their antibacterial effect. Exposure to ECA-NPs increased levels of reactive oxygen species (ROS), which induced oxidative stress, resulting in cellular dysfunction. Here, we report a possible mechanism by which ECA-NPs act on the response of both bacteria to ECA-NPs by evaluating their transcriptome and morphological changes. The results revealed that
B. subtilis
and
E. coli
responded to ECA-NPs using different mechanisms. Unlike wild-type (WT) strains,
E. coli
strains lacking RecA, an essential protein for SOS response, exhibited less sensitivity to ECA-NPs. Moreover, as oxidative damage worsened, a loss of cell membrane integrity is triggered, accompanied by phosphatidylserine (PS) externalization that resembles the hallmarks of eukaryotic apoptosis. Taken together, apoptosis-like death (ALD) is induced in
E. coli
by ROS generation through the presence of ECA-NPs. Meanwhile, ECA-NP-treated
B. subtilis
cells undergo necrosis rather than apoptosis, which is further supported by the results of annexin V/propidium iodide (PI) analysis. |
---|---|
ISSN: | 2051-8153 2051-8161 |
DOI: | 10.1039/D3EN00054K |